Ipsen to Buy Memo Therapeutics to Expand Rare Disease Portfolio
Dow Jones Newswires
Ipsen to Buy Memo Therapeutics to Expand Rare Disease Portfolio
- Sources
- Dow Jones Newswires
- Markets
- Stocks
- Active symbols
- EURONEXT:IPN
- Language
- English
Ipsen to Buy Memo Therapeutics to Expand Rare Disease Portfolio